This enzyme is a critical regulator of VWF function, and another example of starting at the bedside in patients with this puzzling rare genetic disorder, with the genetics then leading us to the ADAMTS13 gene and new insight into the molecular mechanisms underlying TTP. This evidence concerns the gene ADAMTS13 and hereditary disease.